Bioorganic and Medicinal Chemistry Letters p. 1691 - 1696 (1996)
Update date:2022-07-29
Topics:
Dickinson, Roger P.
Dack, Kevin N.
Steele, John
Tute, Michael S.
The design of dual thromboxane synthase inhibitor/thromboxane receptor antagonists (e.g. 15) based on the structure of the thromboxane synthase inhibitor dazmegrel is described. More potent receptor antagonists (e.g. 16c) result from replacement of the pyridinyl substituent with 4-fluorophenyl. Modelling suggests the existence of more than one site capable of interacting with the aryl sulfonamide of TxA2 receptor antagonists.
View MoreHangzhou Eastbiopharm Co.,Ltd.
Contact:+86-571-88931780
Address:Hangzhou,China
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Beijing Century Richap Chemistry Co.,Ltd
Contact:+86- 010-64455497
Address:Guannan County, Lianyungang City, Jiangsu Province, China
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
HENAN SUNLAKE ENTERPRISE CORPORATION
Contact:86--15838116976
Address:Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
Doi:10.1002/ejic.201301287
(2014)Doi:10.1134/S0036024417070226
()Doi:10.1021/jo00126a033
(1995)Doi:10.1021/jo00125a016
(1995)Doi:10.1021/ol101435w
(2010)Doi:10.1016/00404-0399(50)0841Y-
(1995)
